GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP1
|
ENSG00000185591.5 | Sp1 transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SP1 | hg19_v2_chr12_+_53773944_53773993 | -0.52 | 1.6e-16 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_4135693 | 53.96 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr11_+_65686952 | 52.22 |
ENST00000527119.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr12_-_109125285 | 50.58 |
ENST00000552871.1
ENST00000261401.3 |
CORO1C
|
coronin, actin binding protein, 1C |
chr11_+_65686802 | 48.06 |
ENST00000376991.2
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chrX_-_152989798 | 47.34 |
ENST00000441714.1
ENST00000442093.1 ENST00000429550.1 ENST00000345046.6 |
BCAP31
|
B-cell receptor-associated protein 31 |
chr6_-_4135825 | 47.03 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr17_+_37026284 | 46.30 |
ENST00000433206.2
ENST00000435347.3 |
LASP1
|
LIM and SH3 protein 1 |
chr11_+_65686728 | 42.93 |
ENST00000312515.2
ENST00000525501.1 |
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr18_+_3449821 | 42.58 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
chr18_+_3449695 | 40.89 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
chr19_+_54695098 | 39.30 |
ENST00000396388.2
|
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
chr17_+_37026106 | 36.29 |
ENST00000318008.6
|
LASP1
|
LIM and SH3 protein 1 |
chr11_+_64009072 | 35.47 |
ENST00000535135.1
ENST00000394540.3 |
FKBP2
|
FK506 binding protein 2, 13kDa |
chr9_+_131451480 | 35.10 |
ENST00000322030.8
|
SET
|
SET nuclear oncogene |
chr3_-_149688655 | 33.53 |
ENST00000461930.1
ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2
|
profilin 2 |
chr2_+_30369859 | 33.48 |
ENST00000402003.3
|
YPEL5
|
yippee-like 5 (Drosophila) |
chr19_-_50143452 | 33.13 |
ENST00000246792.3
|
RRAS
|
related RAS viral (r-ras) oncogene homolog |
chr19_-_55919087 | 32.95 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
chr11_+_65687158 | 32.65 |
ENST00000532933.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
chr4_-_102268628 | 32.23 |
ENST00000323055.6
ENST00000512215.1 ENST00000394854.3 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr1_+_65886262 | 32.12 |
ENST00000371065.4
|
LEPROT
|
leptin receptor overlapping transcript |
chr19_+_41725088 | 32.06 |
ENST00000301178.4
|
AXL
|
AXL receptor tyrosine kinase |
chr17_-_62658186 | 30.31 |
ENST00000262435.9
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2 |
chrX_+_118370288 | 30.28 |
ENST00000535419.1
|
PGRMC1
|
progesterone receptor membrane component 1 |
chr1_-_68299130 | 30.11 |
ENST00000370982.3
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12 |
chr22_+_38071615 | 29.83 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
chr11_-_64014379 | 29.80 |
ENST00000309318.3
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr12_-_56122426 | 29.65 |
ENST00000551173.1
|
CD63
|
CD63 molecule |
chr17_-_4852332 | 29.61 |
ENST00000572383.1
|
PFN1
|
profilin 1 |
chr19_+_54694119 | 29.38 |
ENST00000456872.1
ENST00000302937.4 ENST00000429671.2 |
TSEN34
|
TSEN34 tRNA splicing endonuclease subunit |
chr2_-_174828892 | 29.23 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
chr2_-_10952832 | 28.86 |
ENST00000540494.1
|
PDIA6
|
protein disulfide isomerase family A, member 6 |
chr11_+_129939811 | 28.42 |
ENST00000345598.5
ENST00000338167.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
chrX_+_54834791 | 28.22 |
ENST00000218439.4
ENST00000375058.1 ENST00000375060.1 |
MAGED2
|
melanoma antigen family D, 2 |
chr1_-_113247543 | 28.00 |
ENST00000414971.1
ENST00000534717.1 |
RHOC
|
ras homolog family member C |
chr12_+_56367697 | 27.94 |
ENST00000553116.1
ENST00000360299.5 ENST00000548068.1 ENST00000549915.1 ENST00000551459.1 ENST00000448789.2 |
RAB5B
|
RAB5B, member RAS oncogene family |
chr6_-_31697255 | 27.80 |
ENST00000436437.1
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2 |
chr14_-_69446034 | 27.72 |
ENST00000193403.6
|
ACTN1
|
actinin, alpha 1 |
chr12_-_118498958 | 27.59 |
ENST00000315436.3
|
WSB2
|
WD repeat and SOCS box containing 2 |
chr8_+_26149007 | 27.52 |
ENST00000380737.3
ENST00000524169.1 |
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
chr1_+_169075554 | 27.41 |
ENST00000367815.4
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr8_+_38854418 | 27.41 |
ENST00000481513.1
ENST00000487273.2 |
ADAM9
|
ADAM metallopeptidase domain 9 |
chr2_+_136289030 | 27.39 |
ENST00000409478.1
ENST00000264160.4 ENST00000329971.3 ENST00000438014.1 |
R3HDM1
|
R3H domain containing 1 |
chr8_-_67976509 | 27.31 |
ENST00000518747.1
|
COPS5
|
COP9 signalosome subunit 5 |
chr1_-_183604794 | 27.26 |
ENST00000367534.1
ENST00000359856.6 ENST00000294742.6 |
ARPC5
|
actin related protein 2/3 complex, subunit 5, 16kDa |
chr9_+_110045537 | 27.26 |
ENST00000358015.3
|
RAD23B
|
RAD23 homolog B (S. cerevisiae) |
chrX_-_152989531 | 27.03 |
ENST00000458587.2
ENST00000416815.1 |
BCAP31
|
B-cell receptor-associated protein 31 |
chr14_-_69445968 | 27.01 |
ENST00000438964.2
|
ACTN1
|
actinin, alpha 1 |
chr22_-_36784035 | 26.69 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
chrX_-_37706815 | 26.55 |
ENST00000378578.4
|
DYNLT3
|
dynein, light chain, Tctex-type 3 |
chr5_+_138089100 | 26.50 |
ENST00000520339.1
ENST00000355078.5 ENST00000302763.7 ENST00000518910.1 |
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa |
chr2_-_9771075 | 26.37 |
ENST00000446619.1
ENST00000238081.3 |
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta |
chr3_+_183892635 | 26.20 |
ENST00000427072.1
ENST00000411763.2 ENST00000292807.5 ENST00000448139.1 ENST00000455925.1 |
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit |
chr12_+_69979113 | 26.07 |
ENST00000299300.6
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr14_-_69445793 | 26.01 |
ENST00000538545.2
ENST00000394419.4 |
ACTN1
|
actinin, alpha 1 |
chr12_+_120933904 | 25.78 |
ENST00000550178.1
ENST00000550845.1 ENST00000549989.1 ENST00000552870.1 |
DYNLL1
|
dynein, light chain, LC8-type 1 |
chr15_+_66161802 | 25.76 |
ENST00000566233.1
ENST00000565075.1 ENST00000435304.2 |
RAB11A
|
RAB11A, member RAS oncogene family |
chrX_-_153775426 | 25.73 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
chr7_+_116139744 | 25.69 |
ENST00000343213.2
|
CAV2
|
caveolin 2 |
chr12_-_49582593 | 25.60 |
ENST00000295766.5
|
TUBA1A
|
tubulin, alpha 1a |
chr17_-_15466850 | 25.47 |
ENST00000438826.3
ENST00000225576.3 ENST00000519970.1 ENST00000518321.1 ENST00000428082.2 ENST00000522212.2 |
TVP23C
TVP23C-CDRT4
|
trans-golgi network vesicle protein 23 homolog C (S. cerevisiae) TVP23C-CDRT4 readthrough |
chr3_-_149688502 | 25.45 |
ENST00000481767.1
ENST00000475518.1 |
PFN2
|
profilin 2 |
chr7_+_26241310 | 25.32 |
ENST00000396386.2
|
CBX3
|
chromobox homolog 3 |
chrX_-_153599578 | 25.23 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
chr7_+_26241325 | 25.18 |
ENST00000456948.1
ENST00000409747.1 |
CBX3
|
chromobox homolog 3 |
chr1_-_113249948 | 25.12 |
ENST00000339083.7
ENST00000369642.3 |
RHOC
|
ras homolog family member C |
chr4_+_174089904 | 24.95 |
ENST00000265000.4
|
GALNT7
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) |
chr8_+_26371763 | 24.78 |
ENST00000521913.1
|
DPYSL2
|
dihydropyrimidinase-like 2 |
chr19_+_48828788 | 24.74 |
ENST00000594198.1
ENST00000597279.1 ENST00000593437.1 |
EMP3
|
epithelial membrane protein 3 |
chr2_+_30369807 | 24.69 |
ENST00000379520.3
ENST00000379519.3 ENST00000261353.4 |
YPEL5
|
yippee-like 5 (Drosophila) |
chr4_-_102268484 | 24.65 |
ENST00000394853.4
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr19_+_36606354 | 24.65 |
ENST00000589996.1
ENST00000591296.1 |
TBCB
|
tubulin folding cofactor B |
chr17_-_15466742 | 24.51 |
ENST00000584811.1
ENST00000419890.2 |
TVP23C
|
trans-golgi network vesicle protein 23 homolog C (S. cerevisiae) |
chr19_+_50180409 | 24.51 |
ENST00000391851.4
|
PRMT1
|
protein arginine methyltransferase 1 |
chr6_-_31697563 | 24.39 |
ENST00000375789.2
ENST00000416410.1 |
DDAH2
|
dimethylarginine dimethylaminohydrolase 2 |
chr10_+_70883908 | 24.32 |
ENST00000263559.6
ENST00000395098.1 ENST00000546041.1 ENST00000541711.1 |
VPS26A
|
vacuolar protein sorting 26 homolog A (S. pombe) |
chr17_-_4852243 | 24.29 |
ENST00000225655.5
|
PFN1
|
profilin 1 |
chr1_+_155290677 | 24.29 |
ENST00000368354.3
ENST00000368352.5 |
RUSC1
|
RUN and SH3 domain containing 1 |
chrX_+_118602363 | 24.27 |
ENST00000317881.8
|
SLC25A5
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
chr1_-_205719295 | 24.22 |
ENST00000367142.4
|
NUCKS1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
chr12_-_46766577 | 24.11 |
ENST00000256689.5
|
SLC38A2
|
solute carrier family 38, member 2 |
chr15_-_72523924 | 24.06 |
ENST00000566809.1
ENST00000567087.1 ENST00000569050.1 ENST00000568883.1 |
PKM
|
pyruvate kinase, muscle |
chr8_-_101963482 | 23.97 |
ENST00000419477.2
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chrX_+_118370211 | 23.80 |
ENST00000217971.7
|
PGRMC1
|
progesterone receptor membrane component 1 |
chr8_-_80942061 | 23.79 |
ENST00000519386.1
|
MRPS28
|
mitochondrial ribosomal protein S28 |
chr20_+_32581452 | 23.57 |
ENST00000375114.3
ENST00000448364.1 |
RALY
|
RALY heterogeneous nuclear ribonucleoprotein |
chr5_+_115177178 | 23.56 |
ENST00000316788.7
|
AP3S1
|
adaptor-related protein complex 3, sigma 1 subunit |
chr6_+_83073952 | 23.55 |
ENST00000543496.1
|
TPBG
|
trophoblast glycoprotein |
chr17_-_80231300 | 23.49 |
ENST00000398519.5
ENST00000580446.1 |
CSNK1D
|
casein kinase 1, delta |
chr19_+_48828582 | 23.46 |
ENST00000270221.6
ENST00000596315.1 |
EMP3
|
epithelial membrane protein 3 |
chr1_+_27022839 | 23.30 |
ENST00000457599.2
|
ARID1A
|
AT rich interactive domain 1A (SWI-like) |
chr2_-_61765315 | 23.23 |
ENST00000406957.1
ENST00000401558.2 |
XPO1
|
exportin 1 (CRM1 homolog, yeast) |
chr20_+_35202909 | 23.23 |
ENST00000558530.1
ENST00000558028.1 ENST00000560025.1 |
TGIF2-C20orf24
TGIF2
|
TGIF2-C20orf24 readthrough TGFB-induced factor homeobox 2 |
chr4_-_39529049 | 23.21 |
ENST00000501493.2
ENST00000509391.1 ENST00000507089.1 |
UGDH
|
UDP-glucose 6-dehydrogenase |
chr19_-_48894762 | 23.14 |
ENST00000600980.1
ENST00000330720.2 |
KDELR1
|
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 |
chr20_+_43514320 | 22.91 |
ENST00000372839.3
ENST00000428262.1 ENST00000445830.1 |
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
chr8_+_61429728 | 22.91 |
ENST00000529579.1
|
RAB2A
|
RAB2A, member RAS oncogene family |
chr3_+_33155525 | 22.80 |
ENST00000449224.1
|
CRTAP
|
cartilage associated protein |
chr20_+_56884752 | 22.75 |
ENST00000244040.3
|
RAB22A
|
RAB22A, member RAS oncogene family |
chr16_-_81129845 | 22.62 |
ENST00000569885.1
ENST00000566566.1 |
GCSH
|
glycine cleavage system protein H (aminomethyl carrier) |
chr17_-_4269768 | 22.59 |
ENST00000396981.2
|
UBE2G1
|
ubiquitin-conjugating enzyme E2G 1 |
chr7_-_72936531 | 22.56 |
ENST00000339594.4
|
BAZ1B
|
bromodomain adjacent to zinc finger domain, 1B |
chr6_-_31704282 | 22.50 |
ENST00000375784.3
ENST00000375779.2 |
CLIC1
|
chloride intracellular channel 1 |
chr2_+_187454749 | 22.46 |
ENST00000261023.3
ENST00000374907.3 |
ITGAV
|
integrin, alpha V |
chr6_-_86352982 | 22.36 |
ENST00000369622.3
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
chr19_+_50180317 | 22.26 |
ENST00000534465.1
|
PRMT1
|
protein arginine methyltransferase 1 |
chr2_-_230786679 | 22.22 |
ENST00000543084.1
ENST00000343290.5 ENST00000389044.4 ENST00000283943.5 |
TRIP12
|
thyroid hormone receptor interactor 12 |
chr22_-_19165917 | 22.18 |
ENST00000451283.1
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
chr7_-_5569588 | 22.08 |
ENST00000417101.1
|
ACTB
|
actin, beta |
chr11_+_64008443 | 22.04 |
ENST00000309366.4
|
FKBP2
|
FK506 binding protein 2, 13kDa |
chr10_+_114709999 | 22.02 |
ENST00000355995.4
ENST00000545257.1 ENST00000543371.1 ENST00000536810.1 ENST00000355717.4 ENST00000538897.1 ENST00000534894.1 |
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box) |
chr12_+_120933859 | 22.01 |
ENST00000242577.6
ENST00000548214.1 ENST00000392508.2 |
DYNLL1
|
dynein, light chain, LC8-type 1 |
chr7_-_16685422 | 22.00 |
ENST00000306999.2
|
ANKMY2
|
ankyrin repeat and MYND domain containing 2 |
chrX_+_106871713 | 22.00 |
ENST00000372435.4
ENST00000372428.4 ENST00000372419.3 ENST00000543248.1 |
PRPS1
|
phosphoribosyl pyrophosphate synthetase 1 |
chr1_+_160175201 | 21.90 |
ENST00000368076.1
|
PEA15
|
phosphoprotein enriched in astrocytes 15 |
chr4_-_157892498 | 21.89 |
ENST00000502773.1
|
PDGFC
|
platelet derived growth factor C |
chr10_-_126849588 | 21.84 |
ENST00000411419.2
|
CTBP2
|
C-terminal binding protein 2 |
chr11_-_67169265 | 21.69 |
ENST00000358239.4
ENST00000376745.4 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
chr1_+_26606608 | 21.58 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr6_+_30689350 | 21.57 |
ENST00000330914.3
|
TUBB
|
tubulin, beta class I |
chr15_+_66679155 | 21.55 |
ENST00000307102.5
|
MAP2K1
|
mitogen-activated protein kinase kinase 1 |
chr20_+_43514315 | 21.37 |
ENST00000353703.4
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
chr20_+_32581525 | 21.36 |
ENST00000246194.3
ENST00000413297.1 |
RALY
|
RALY heterogeneous nuclear ribonucleoprotein |
chr1_+_47799446 | 21.34 |
ENST00000371873.5
|
CMPK1
|
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic |
chr12_-_56122761 | 21.30 |
ENST00000552164.1
ENST00000420846.3 ENST00000257857.4 |
CD63
|
CD63 molecule |
chr11_-_67169253 | 21.28 |
ENST00000527663.1
ENST00000312989.7 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
chr14_+_53173910 | 21.28 |
ENST00000606149.1
ENST00000555339.1 ENST00000556813.1 |
PSMC6
|
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
chr5_+_172410757 | 21.17 |
ENST00000519374.1
ENST00000519911.1 ENST00000265093.4 ENST00000517669.1 |
ATP6V0E1
|
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 |
chrX_+_54835493 | 21.17 |
ENST00000396224.1
|
MAGED2
|
melanoma antigen family D, 2 |
chr15_-_64995399 | 21.04 |
ENST00000559753.1
ENST00000560258.2 ENST00000559912.2 ENST00000326005.6 |
OAZ2
|
ornithine decarboxylase antizyme 2 |
chr1_-_113249678 | 20.98 |
ENST00000369633.2
ENST00000425265.2 ENST00000369632.2 ENST00000436685.2 |
RHOC
|
ras homolog family member C |
chr14_+_53173890 | 20.91 |
ENST00000445930.2
|
PSMC6
|
proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
chr17_+_34900737 | 20.87 |
ENST00000304718.4
ENST00000485685.2 |
GGNBP2
|
gametogenetin binding protein 2 |
chr2_-_64881018 | 20.83 |
ENST00000313349.3
|
SERTAD2
|
SERTA domain containing 2 |
chr20_-_49547731 | 20.79 |
ENST00000396029.3
|
ADNP
|
activity-dependent neuroprotector homeobox |
chr2_+_172778952 | 20.78 |
ENST00000392584.1
ENST00000264108.4 |
HAT1
|
histone acetyltransferase 1 |
chr19_-_55791431 | 20.75 |
ENST00000593263.1
ENST00000376343.3 |
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
chr20_+_17550489 | 20.66 |
ENST00000246069.7
|
DSTN
|
destrin (actin depolymerizing factor) |
chr16_+_2563871 | 20.65 |
ENST00000330398.4
ENST00000568562.1 ENST00000569317.1 |
ATP6V0C
ATP6C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c Uncharacterized protein |
chr11_+_129939779 | 20.58 |
ENST00000533195.1
ENST00000533713.1 ENST00000528499.1 ENST00000539648.1 ENST00000263574.5 |
APLP2
|
amyloid beta (A4) precursor-like protein 2 |
chr11_-_65626753 | 20.55 |
ENST00000526975.1
ENST00000531413.1 |
CFL1
|
cofilin 1 (non-muscle) |
chr11_+_34938119 | 20.38 |
ENST00000227868.4
ENST00000430469.2 ENST00000533262.1 |
PDHX
|
pyruvate dehydrogenase complex, component X |
chr22_+_41347363 | 20.30 |
ENST00000216225.8
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase |
chr19_+_50180507 | 20.26 |
ENST00000454376.2
ENST00000524771.1 |
PRMT1
|
protein arginine methyltransferase 1 |
chr19_+_47104493 | 20.25 |
ENST00000291295.9
ENST00000597743.1 |
CALM3
|
calmodulin 3 (phosphorylase kinase, delta) |
chr20_+_17550691 | 20.21 |
ENST00000474024.1
|
DSTN
|
destrin (actin depolymerizing factor) |
chr4_-_100871506 | 20.21 |
ENST00000296417.5
|
H2AFZ
|
H2A histone family, member Z |
chr4_+_166248775 | 20.20 |
ENST00000261507.6
ENST00000507013.1 ENST00000393766.2 ENST00000504317.1 |
MSMO1
|
methylsterol monooxygenase 1 |
chr16_+_730063 | 20.15 |
ENST00000565677.1
ENST00000219548.4 |
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
chr20_+_306221 | 20.15 |
ENST00000342665.2
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr19_+_36606654 | 20.13 |
ENST00000588385.1
ENST00000585746.1 |
TBCB
|
tubulin folding cofactor B |
chr19_+_36631867 | 20.12 |
ENST00000588780.1
|
CAPNS1
|
calpain, small subunit 1 |
chr15_+_52311398 | 20.08 |
ENST00000261845.5
|
MAPK6
|
mitogen-activated protein kinase 6 |
chr3_+_105085734 | 20.08 |
ENST00000306107.5
|
ALCAM
|
activated leukocyte cell adhesion molecule |
chr17_+_48133459 | 20.03 |
ENST00000320031.8
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
chr1_+_166808692 | 20.03 |
ENST00000367876.4
|
POGK
|
pogo transposable element with KRAB domain |
chr12_-_57081940 | 20.02 |
ENST00000436399.2
|
PTGES3
|
prostaglandin E synthase 3 (cytosolic) |
chr1_+_165797024 | 20.00 |
ENST00000372212.4
|
UCK2
|
uridine-cytidine kinase 2 |
chr16_-_29466285 | 19.83 |
ENST00000330978.3
|
BOLA2
|
bolA family member 2 |
chr1_-_65432171 | 19.81 |
ENST00000342505.4
|
JAK1
|
Janus kinase 1 |
chr6_+_30689401 | 19.61 |
ENST00000396389.1
ENST00000396384.1 |
TUBB
|
tubulin, beta class I |
chr2_+_27651478 | 19.58 |
ENST00000379852.3
|
NRBP1
|
nuclear receptor binding protein 1 |
chr7_+_127228399 | 19.56 |
ENST00000000233.5
ENST00000415666.1 |
ARF5
|
ADP-ribosylation factor 5 |
chrX_-_16888448 | 19.52 |
ENST00000468092.1
ENST00000404022.1 ENST00000380087.2 |
RBBP7
|
retinoblastoma binding protein 7 |
chr12_+_69979210 | 19.52 |
ENST00000544368.2
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta) |
chr14_-_24615805 | 19.47 |
ENST00000560410.1
|
PSME2
|
proteasome (prosome, macropain) activator subunit 2 (PA28 beta) |
chr3_-_53290016 | 19.32 |
ENST00000423525.2
ENST00000423516.1 ENST00000296289.6 ENST00000462138.1 |
TKT
|
transketolase |
chr16_-_81129951 | 19.13 |
ENST00000315467.3
|
GCSH
|
glycine cleavage system protein H (aminomethyl carrier) |
chr15_-_72523454 | 19.13 |
ENST00000565154.1
ENST00000565184.1 ENST00000389093.3 ENST00000449901.2 ENST00000335181.5 ENST00000319622.6 |
PKM
|
pyruvate kinase, muscle |
chr20_+_62371206 | 19.08 |
ENST00000266077.2
|
SLC2A4RG
|
SLC2A4 regulator |
chr20_-_48330377 | 19.06 |
ENST00000371711.4
|
B4GALT5
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 |
chr4_-_103748271 | 19.03 |
ENST00000343106.5
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3 |
chr11_+_64008525 | 19.02 |
ENST00000449942.2
|
FKBP2
|
FK506 binding protein 2, 13kDa |
chr16_+_3068393 | 18.96 |
ENST00000573001.1
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A |
chr12_-_76477707 | 18.94 |
ENST00000551992.1
|
NAP1L1
|
nucleosome assembly protein 1-like 1 |
chrX_+_77359671 | 18.90 |
ENST00000373316.4
|
PGK1
|
phosphoglycerate kinase 1 |
chrX_+_77359726 | 18.89 |
ENST00000442431.1
|
PGK1
|
phosphoglycerate kinase 1 |
chr2_+_10442993 | 18.79 |
ENST00000423674.1
ENST00000307845.3 |
HPCAL1
|
hippocalcin-like 1 |
chr16_+_56691911 | 18.66 |
ENST00000568475.1
|
MT1F
|
metallothionein 1F |
chr2_-_200322723 | 18.61 |
ENST00000417098.1
|
SATB2
|
SATB homeobox 2 |
chr2_-_161350305 | 18.46 |
ENST00000348849.3
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
chr17_-_46178527 | 18.39 |
ENST00000393408.3
|
CBX1
|
chromobox homolog 1 |
chr1_-_85742773 | 18.38 |
ENST00000370580.1
|
BCL10
|
B-cell CLL/lymphoma 10 |
chr22_-_19166343 | 18.35 |
ENST00000215882.5
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
chr2_+_235860616 | 18.34 |
ENST00000392011.2
|
SH3BP4
|
SH3-domain binding protein 4 |
chr16_+_56691838 | 18.32 |
ENST00000394501.2
|
MT1F
|
metallothionein 1F |
chr10_+_75910960 | 18.32 |
ENST00000539909.1
ENST00000286621.2 |
ADK
|
adenosine kinase |
chr10_-_33246722 | 18.27 |
ENST00000437302.1
ENST00000396033.2 |
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
chr1_+_26798955 | 18.27 |
ENST00000361427.5
|
HMGN2
|
high mobility group nucleosomal binding domain 2 |
chr5_-_57756087 | 18.24 |
ENST00000274289.3
|
PLK2
|
polo-like kinase 2 |
chr2_+_242255297 | 18.20 |
ENST00000401990.1
ENST00000407971.1 ENST00000436795.1 ENST00000411484.1 ENST00000434955.1 ENST00000402092.2 ENST00000441533.1 ENST00000443492.1 ENST00000437066.1 ENST00000429791.1 |
SEPT2
|
septin 2 |
chr2_+_242255275 | 18.14 |
ENST00000391971.2
|
SEPT2
|
septin 2 |
chr1_-_6453426 | 18.13 |
ENST00000545482.1
|
ACOT7
|
acyl-CoA thioesterase 7 |
chr7_+_143078652 | 18.12 |
ENST00000354434.4
ENST00000449423.2 |
ZYX
|
zyxin |
chr12_+_51632638 | 18.10 |
ENST00000549732.2
|
DAZAP2
|
DAZ associated protein 2 |
chr1_-_26232522 | 18.07 |
ENST00000399728.1
|
STMN1
|
stathmin 1 |
chr1_-_225840747 | 18.04 |
ENST00000366843.2
ENST00000366844.3 |
ENAH
|
enabled homolog (Drosophila) |
chr12_+_69004619 | 18.04 |
ENST00000250559.9
ENST00000393436.5 ENST00000425247.2 ENST00000489473.2 ENST00000422358.2 ENST00000541167.1 ENST00000538283.1 ENST00000341355.5 ENST00000537460.1 ENST00000450214.2 ENST00000545270.1 ENST00000538980.1 ENST00000542018.1 ENST00000543393.1 |
RAP1B
|
RAP1B, member of RAS oncogene family |
chr3_-_149688896 | 18.01 |
ENST00000239940.7
|
PFN2
|
profilin 2 |
chr19_+_6361754 | 18.01 |
ENST00000597326.1
|
CLPP
|
caseinolytic mitochondrial matrix peptidase proteolytic subunit |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.9 | 68.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
22.6 | 67.8 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
21.2 | 63.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
18.3 | 109.9 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
17.0 | 68.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
15.1 | 75.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
13.2 | 52.8 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
13.0 | 39.1 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
12.8 | 38.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
11.9 | 47.8 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
11.1 | 11.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
10.7 | 32.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
10.7 | 32.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
10.6 | 63.7 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
10.6 | 42.4 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
10.6 | 63.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
10.6 | 31.7 | GO:0044209 | AMP salvage(GO:0044209) |
10.4 | 31.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
10.3 | 62.0 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
10.2 | 30.6 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
10.1 | 40.3 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
10.0 | 70.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
10.0 | 30.0 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
10.0 | 29.9 | GO:0002188 | translation reinitiation(GO:0002188) |
9.9 | 29.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
9.9 | 108.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
9.9 | 29.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
9.7 | 87.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
9.6 | 28.9 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
9.6 | 67.4 | GO:1900045 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
9.5 | 66.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
9.5 | 38.2 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
9.5 | 9.5 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
9.5 | 9.5 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
9.4 | 65.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
9.4 | 47.0 | GO:0035900 | response to isolation stress(GO:0035900) |
9.4 | 37.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
9.3 | 46.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
9.2 | 27.6 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
9.0 | 36.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
8.9 | 26.7 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
8.8 | 26.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
8.7 | 43.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
8.6 | 34.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
8.5 | 25.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
8.4 | 125.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
8.2 | 41.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
8.2 | 32.6 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
8.1 | 40.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
8.1 | 40.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
8.1 | 32.2 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
8.0 | 16.0 | GO:1902903 | regulation of fibril organization(GO:1902903) |
7.9 | 23.6 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
7.8 | 23.5 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
7.6 | 68.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
7.5 | 113.0 | GO:0051639 | actin filament network formation(GO:0051639) |
7.5 | 67.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
7.3 | 22.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
7.3 | 36.6 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
7.3 | 29.1 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
7.2 | 43.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
7.1 | 113.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
7.0 | 21.0 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
7.0 | 83.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
6.9 | 34.6 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
6.9 | 20.7 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
6.8 | 20.4 | GO:1902822 | regulation of late endosome to lysosome transport(GO:1902822) |
6.7 | 13.5 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
6.7 | 6.7 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
6.7 | 40.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
6.7 | 26.7 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
6.6 | 33.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
6.6 | 33.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
6.5 | 52.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
6.4 | 19.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
6.4 | 51.5 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
6.4 | 51.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
6.3 | 25.1 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
6.3 | 18.8 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
6.2 | 24.7 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
6.1 | 18.4 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
6.1 | 67.1 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
6.1 | 30.4 | GO:0030047 | actin modification(GO:0030047) |
6.1 | 18.2 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
6.1 | 42.5 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
6.1 | 96.9 | GO:0000338 | protein deneddylation(GO:0000338) |
6.0 | 35.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
5.9 | 29.7 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
5.9 | 5.9 | GO:1902667 | regulation of axon guidance(GO:1902667) |
5.8 | 5.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
5.8 | 23.3 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
5.8 | 17.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
5.8 | 17.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
5.8 | 11.5 | GO:0006983 | ER overload response(GO:0006983) |
5.7 | 5.7 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
5.7 | 22.9 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
5.7 | 17.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
5.7 | 34.2 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
5.7 | 5.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
5.6 | 5.6 | GO:0015698 | inorganic anion transport(GO:0015698) |
5.6 | 33.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
5.6 | 16.9 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
5.6 | 11.2 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
5.6 | 33.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
5.6 | 39.1 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
5.5 | 72.1 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
5.5 | 38.7 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
5.5 | 16.5 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
5.4 | 102.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
5.4 | 16.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
5.3 | 10.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
5.3 | 31.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
5.3 | 10.6 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
5.3 | 31.7 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
5.3 | 21.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
5.2 | 5.2 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
5.2 | 21.0 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
5.2 | 15.7 | GO:0007412 | axon target recognition(GO:0007412) |
5.2 | 20.7 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
5.2 | 36.1 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
5.1 | 5.1 | GO:1903911 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
5.1 | 20.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
5.1 | 20.3 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
5.1 | 5.1 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
5.1 | 20.2 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
5.1 | 15.2 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
5.0 | 5.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
5.0 | 20.1 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
5.0 | 10.0 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
5.0 | 30.0 | GO:0015853 | adenine transport(GO:0015853) |
5.0 | 49.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
5.0 | 19.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
5.0 | 14.9 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
4.9 | 14.8 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
4.9 | 24.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
4.9 | 14.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
4.8 | 14.5 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
4.8 | 19.2 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
4.8 | 14.4 | GO:0061198 | fungiform papilla formation(GO:0061198) |
4.8 | 9.6 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
4.8 | 4.8 | GO:0052255 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
4.8 | 28.6 | GO:0030421 | defecation(GO:0030421) |
4.8 | 14.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
4.8 | 76.2 | GO:0043248 | proteasome assembly(GO:0043248) |
4.7 | 19.0 | GO:0043335 | protein unfolding(GO:0043335) |
4.7 | 14.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
4.7 | 4.7 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
4.7 | 42.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
4.7 | 47.1 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
4.6 | 32.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
4.6 | 18.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
4.6 | 27.8 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
4.6 | 32.3 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
4.6 | 23.0 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
4.6 | 27.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
4.6 | 22.8 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
4.5 | 22.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
4.5 | 9.0 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
4.5 | 197.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
4.4 | 17.7 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
4.4 | 17.5 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
4.4 | 26.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
4.3 | 13.0 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
4.3 | 34.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
4.3 | 21.5 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
4.3 | 12.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
4.3 | 21.3 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
4.3 | 12.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
4.2 | 8.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
4.2 | 21.0 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
4.2 | 12.6 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
4.2 | 8.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
4.2 | 25.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
4.2 | 16.7 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
4.2 | 24.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
4.1 | 16.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
4.1 | 12.4 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
4.1 | 12.3 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
4.1 | 61.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
4.0 | 28.1 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
4.0 | 56.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
4.0 | 12.0 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
4.0 | 16.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
4.0 | 12.0 | GO:0009180 | ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
4.0 | 39.9 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
4.0 | 19.9 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
4.0 | 19.9 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
3.9 | 66.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
3.9 | 19.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
3.9 | 50.7 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
3.9 | 11.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
3.9 | 15.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
3.8 | 15.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
3.8 | 285.3 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
3.8 | 22.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
3.8 | 11.3 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
3.8 | 56.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
3.8 | 11.3 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
3.7 | 22.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
3.7 | 14.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
3.7 | 48.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
3.7 | 18.4 | GO:0015862 | uridine transport(GO:0015862) |
3.7 | 36.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
3.7 | 7.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
3.7 | 11.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
3.7 | 11.0 | GO:1990910 | response to hypobaric hypoxia(GO:1990910) |
3.7 | 25.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
3.7 | 22.0 | GO:0032328 | alanine transport(GO:0032328) |
3.7 | 36.5 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
3.7 | 36.5 | GO:0010265 | SCF complex assembly(GO:0010265) |
3.6 | 3.6 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
3.6 | 14.4 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
3.6 | 14.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
3.6 | 3.6 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
3.6 | 7.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
3.6 | 35.7 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
3.6 | 10.7 | GO:0060613 | fat pad development(GO:0060613) |
3.5 | 7.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
3.5 | 10.6 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
3.5 | 10.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
3.5 | 151.8 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
3.5 | 3.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
3.5 | 13.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.5 | 6.9 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
3.5 | 34.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
3.5 | 69.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
3.5 | 24.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
3.4 | 10.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
3.4 | 6.9 | GO:0046292 | spermatid nucleus elongation(GO:0007290) formaldehyde metabolic process(GO:0046292) |
3.4 | 20.5 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
3.4 | 10.2 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
3.4 | 27.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
3.4 | 20.4 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
3.4 | 6.8 | GO:0051036 | regulation of endosome size(GO:0051036) |
3.4 | 6.7 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
3.3 | 56.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
3.3 | 20.0 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
3.3 | 3.3 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
3.3 | 13.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
3.3 | 20.0 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
3.3 | 26.6 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
3.3 | 3.3 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
3.3 | 6.6 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
3.3 | 32.9 | GO:0007144 | female meiosis I(GO:0007144) |
3.3 | 55.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
3.3 | 16.4 | GO:1902336 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
3.2 | 3.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
3.2 | 35.6 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
3.2 | 64.6 | GO:0032060 | bleb assembly(GO:0032060) |
3.2 | 9.7 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
3.2 | 19.2 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
3.2 | 9.6 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
3.2 | 12.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
3.2 | 3.2 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
3.2 | 107.4 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
3.1 | 9.4 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
3.1 | 12.3 | GO:0046782 | regulation of viral transcription(GO:0046782) |
3.1 | 9.2 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
3.1 | 3.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
3.1 | 12.2 | GO:1902544 | oxidative DNA demethylation(GO:0035511) regulation of DNA N-glycosylase activity(GO:1902544) |
3.1 | 3.1 | GO:0097368 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
3.0 | 48.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
3.0 | 14.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
3.0 | 3.0 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
3.0 | 95.1 | GO:0090383 | phagosome acidification(GO:0090383) |
3.0 | 23.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
3.0 | 14.8 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
3.0 | 3.0 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
2.9 | 85.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.9 | 11.7 | GO:0032218 | riboflavin transport(GO:0032218) |
2.9 | 11.6 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.9 | 5.8 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
2.9 | 8.7 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
2.9 | 31.8 | GO:0006265 | DNA topological change(GO:0006265) |
2.9 | 5.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
2.8 | 8.5 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
2.8 | 14.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.8 | 2.8 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
2.8 | 5.7 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
2.8 | 11.4 | GO:0009956 | radial pattern formation(GO:0009956) |
2.8 | 22.7 | GO:0060056 | mammary gland involution(GO:0060056) |
2.8 | 8.4 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
2.8 | 16.8 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
2.8 | 22.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
2.8 | 8.3 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
2.8 | 5.5 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
2.8 | 11.1 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
2.8 | 2.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
2.7 | 123.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
2.7 | 10.9 | GO:0021564 | vagus nerve development(GO:0021564) |
2.7 | 10.9 | GO:0046502 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
2.7 | 8.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
2.7 | 13.6 | GO:0003164 | His-Purkinje system development(GO:0003164) |
2.7 | 8.1 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
2.7 | 10.8 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
2.7 | 18.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
2.7 | 59.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
2.7 | 26.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
2.7 | 2.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
2.7 | 5.3 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
2.6 | 7.9 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
2.6 | 10.6 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
2.6 | 10.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
2.6 | 10.5 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
2.6 | 2.6 | GO:0021539 | subthalamus development(GO:0021539) |
2.6 | 18.3 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
2.6 | 7.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
2.6 | 7.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.6 | 2.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
2.6 | 95.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
2.6 | 33.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
2.6 | 7.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
2.5 | 7.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
2.5 | 2.5 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
2.5 | 2.5 | GO:0019858 | cytosine metabolic process(GO:0019858) |
2.5 | 7.5 | GO:0050923 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
2.5 | 7.5 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
2.5 | 17.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
2.5 | 7.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
2.5 | 5.0 | GO:1904044 | response to aldosterone(GO:1904044) |
2.5 | 15.0 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
2.5 | 10.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
2.5 | 5.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.5 | 7.4 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
2.5 | 12.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
2.5 | 9.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
2.5 | 22.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.5 | 4.9 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
2.5 | 4.9 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
2.5 | 9.8 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
2.5 | 14.7 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
2.4 | 7.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
2.4 | 9.8 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
2.4 | 7.3 | GO:0007616 | long-term memory(GO:0007616) |
2.4 | 178.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
2.4 | 4.9 | GO:0006740 | NADPH regeneration(GO:0006740) |
2.4 | 4.9 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
2.4 | 12.1 | GO:1901159 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
2.4 | 4.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
2.4 | 16.9 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
2.4 | 2.4 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
2.4 | 9.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
2.4 | 16.7 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
2.4 | 16.6 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
2.4 | 18.9 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
2.4 | 75.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
2.4 | 2.4 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
2.4 | 14.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
2.4 | 173.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
2.3 | 23.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
2.3 | 18.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
2.3 | 11.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
2.3 | 4.7 | GO:0042256 | mature ribosome assembly(GO:0042256) |
2.3 | 46.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
2.3 | 2.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
2.3 | 11.6 | GO:0003068 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
2.3 | 9.2 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
2.3 | 6.9 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
2.3 | 18.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
2.3 | 11.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
2.3 | 9.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
2.3 | 18.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
2.2 | 4.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
2.2 | 2.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
2.2 | 11.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
2.2 | 13.3 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
2.2 | 4.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
2.2 | 6.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.2 | 2.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
2.2 | 13.2 | GO:0007296 | vitellogenesis(GO:0007296) |
2.2 | 54.9 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
2.2 | 13.1 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
2.2 | 8.7 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
2.2 | 23.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.1 | 8.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
2.1 | 8.6 | GO:2000230 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
2.1 | 17.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
2.1 | 44.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
2.1 | 65.5 | GO:0006101 | citrate metabolic process(GO:0006101) |
2.1 | 25.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
2.1 | 2.1 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
2.1 | 8.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
2.1 | 24.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
2.0 | 6.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
2.0 | 14.2 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
2.0 | 14.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
2.0 | 28.4 | GO:0007097 | nuclear migration(GO:0007097) |
2.0 | 6.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
2.0 | 10.1 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
2.0 | 8.1 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
2.0 | 2.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
2.0 | 8.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
2.0 | 12.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
2.0 | 17.8 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
2.0 | 11.8 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
2.0 | 17.6 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
2.0 | 7.8 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.9 | 13.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
1.9 | 5.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
1.9 | 19.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
1.9 | 42.7 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
1.9 | 3.9 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
1.9 | 15.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.9 | 9.6 | GO:0016128 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
1.9 | 17.3 | GO:0042407 | cristae formation(GO:0042407) |
1.9 | 11.5 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
1.9 | 24.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.9 | 7.6 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
1.9 | 3.8 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
1.9 | 5.6 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
1.9 | 24.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.9 | 15.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.9 | 7.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
1.9 | 33.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.9 | 26.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
1.9 | 1.9 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
1.9 | 7.4 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
1.9 | 18.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.9 | 3.7 | GO:0015866 | ADP transport(GO:0015866) |
1.8 | 20.1 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.8 | 16.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.8 | 3.6 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
1.8 | 9.1 | GO:0001878 | response to yeast(GO:0001878) |
1.8 | 16.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.8 | 25.4 | GO:0045116 | protein neddylation(GO:0045116) |
1.8 | 5.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.8 | 12.5 | GO:0072718 | response to cisplatin(GO:0072718) |
1.8 | 17.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.8 | 1.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
1.8 | 28.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
1.8 | 7.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
1.8 | 3.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.8 | 10.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.8 | 7.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.8 | 3.6 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
1.8 | 5.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.8 | 7.1 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
1.7 | 19.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.7 | 17.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.7 | 17.4 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
1.7 | 8.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
1.7 | 12.1 | GO:0030091 | protein repair(GO:0030091) |
1.7 | 12.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.7 | 13.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.7 | 24.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
1.7 | 41.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
1.7 | 8.6 | GO:0002084 | protein depalmitoylation(GO:0002084) |
1.7 | 6.8 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.7 | 1.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
1.7 | 3.4 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
1.7 | 5.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
1.7 | 3.4 | GO:0006404 | RNA import into nucleus(GO:0006404) |
1.7 | 18.5 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
1.7 | 21.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.7 | 16.8 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
1.7 | 1.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.7 | 13.4 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
1.7 | 11.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
1.7 | 6.6 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
1.7 | 67.8 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.7 | 46.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
1.6 | 3.3 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
1.6 | 101.8 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
1.6 | 16.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.6 | 8.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.6 | 4.9 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
1.6 | 16.3 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
1.6 | 6.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.6 | 79.2 | GO:0070671 | response to interleukin-12(GO:0070671) |
1.6 | 25.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.6 | 9.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.6 | 8.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.6 | 4.8 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
1.6 | 3.2 | GO:0035989 | tendon development(GO:0035989) |
1.6 | 1.6 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
1.6 | 3.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.6 | 9.6 | GO:0051012 | microtubule sliding(GO:0051012) |
1.6 | 1.6 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.6 | 31.9 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.6 | 23.7 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.6 | 4.7 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.6 | 4.7 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.6 | 7.8 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.6 | 9.4 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
1.6 | 3.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
1.6 | 25.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.6 | 4.7 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
1.6 | 4.7 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
1.6 | 9.3 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
1.6 | 6.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.6 | 7.8 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.5 | 18.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.5 | 15.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.5 | 12.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
1.5 | 9.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.5 | 40.5 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
1.5 | 19.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.5 | 1.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.5 | 4.5 | GO:1903333 | regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
1.5 | 2.9 | GO:0009303 | rRNA transcription(GO:0009303) |
1.5 | 8.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.5 | 17.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.5 | 11.8 | GO:0051601 | exocyst localization(GO:0051601) |
1.5 | 2.9 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
1.5 | 5.8 | GO:2000630 | regulation of miRNA metabolic process(GO:2000628) positive regulation of miRNA metabolic process(GO:2000630) |
1.5 | 1.5 | GO:0051673 | pore formation in membrane of other organism(GO:0035915) membrane disruption in other organism(GO:0051673) |
1.5 | 14.6 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
1.4 | 13.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.4 | 5.8 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
1.4 | 7.2 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
1.4 | 5.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
1.4 | 1.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
1.4 | 2.9 | GO:0035897 | proteolysis in other organism(GO:0035897) |
1.4 | 11.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
1.4 | 8.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.4 | 15.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.4 | 5.7 | GO:0031017 | exocrine pancreas development(GO:0031017) |
1.4 | 24.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
1.4 | 15.5 | GO:0070986 | left/right axis specification(GO:0070986) |
1.4 | 8.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.4 | 2.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.4 | 35.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.4 | 11.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.4 | 11.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
1.4 | 2.8 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
1.4 | 15.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.4 | 5.6 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.4 | 5.6 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
1.4 | 4.2 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
1.4 | 16.7 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
1.4 | 11.1 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
1.4 | 11.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.4 | 26.1 | GO:0006465 | signal peptide processing(GO:0006465) |
1.4 | 17.9 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
1.4 | 9.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
1.4 | 6.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.4 | 5.4 | GO:0042761 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
1.4 | 70.6 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
1.4 | 5.4 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
1.4 | 81.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
1.3 | 2.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
1.3 | 5.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.3 | 1.3 | GO:0035973 | aggrephagy(GO:0035973) |
1.3 | 9.3 | GO:0070141 | response to UV-A(GO:0070141) |
1.3 | 8.0 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
1.3 | 1.3 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
1.3 | 1.3 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.3 | 10.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.3 | 9.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
1.3 | 9.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.3 | 7.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.3 | 3.9 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
1.3 | 2.6 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
1.3 | 25.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.3 | 6.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.3 | 3.8 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
1.3 | 2.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
1.3 | 11.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.3 | 7.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.3 | 3.8 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.3 | 13.8 | GO:0048569 | post-embryonic organ development(GO:0048569) |
1.3 | 7.5 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
1.2 | 10.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.2 | 17.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
1.2 | 3.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.2 | 17.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.2 | 3.7 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
1.2 | 8.6 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
1.2 | 1.2 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
1.2 | 6.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.2 | 4.9 | GO:0033216 | copper ion import(GO:0015677) ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
1.2 | 6.1 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
1.2 | 12.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.2 | 4.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.2 | 9.6 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.2 | 1.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.2 | 4.8 | GO:0001765 | membrane raft assembly(GO:0001765) |
1.2 | 5.9 | GO:0060356 | leucine import(GO:0060356) |
1.2 | 2.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
1.2 | 1.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.2 | 7.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.2 | 3.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) regulation of immunological synapse formation(GO:2000520) negative regulation of immunological synapse formation(GO:2000521) negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001189) |
1.2 | 3.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.2 | 3.5 | GO:0060416 | response to growth hormone(GO:0060416) |
1.2 | 8.2 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.2 | 3.5 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
1.2 | 7.0 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
1.2 | 14.0 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
1.2 | 3.5 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.2 | 2.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
1.2 | 1.2 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
1.2 | 1.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.2 | 3.5 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) positive regulation of telomeric DNA binding(GO:1904744) |
1.2 | 5.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.2 | 2.3 | GO:0060166 | olfactory pit development(GO:0060166) |
1.1 | 8.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.1 | 5.7 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
1.1 | 4.6 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
1.1 | 3.4 | GO:0001845 | phagolysosome assembly(GO:0001845) |
1.1 | 3.4 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
1.1 | 17.0 | GO:0046039 | GTP metabolic process(GO:0046039) |
1.1 | 13.5 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
1.1 | 4.5 | GO:1901098 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
1.1 | 15.6 | GO:0044804 | nucleophagy(GO:0044804) |
1.1 | 4.4 | GO:0003409 | optic cup structural organization(GO:0003409) |
1.1 | 3.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
1.1 | 11.0 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.1 | 18.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.1 | 3.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.1 | 27.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.1 | 4.4 | GO:1904796 | regulation of core promoter binding(GO:1904796) |
1.1 | 2.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
1.1 | 3.3 | GO:0006565 | cysteine biosynthetic process from serine(GO:0006535) L-serine catabolic process(GO:0006565) |
1.1 | 6.5 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.1 | 2.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.1 | 26.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
1.1 | 4.3 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.1 | 9.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
1.1 | 10.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
1.1 | 5.3 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.1 | 3.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
1.1 | 14.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.1 | 6.4 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
1.1 | 3.2 | GO:0070631 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
1.1 | 1.1 | GO:0070613 | regulation of protein processing(GO:0070613) |
1.0 | 3.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.0 | 2.1 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
1.0 | 7.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.0 | 21.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.0 | 2.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.0 | 2.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
1.0 | 1.0 | GO:1990267 | response to transition metal nanoparticle(GO:1990267) |
1.0 | 3.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.0 | 12.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.0 | 7.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
1.0 | 28.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.0 | 18.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.0 | 6.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.0 | 17.3 | GO:0060325 | face morphogenesis(GO:0060325) |
1.0 | 4.1 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
1.0 | 15.2 | GO:0097205 | renal filtration(GO:0097205) |
1.0 | 5.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.0 | 4.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
1.0 | 3.0 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
1.0 | 4.0 | GO:0051451 | myoblast migration(GO:0051451) |
1.0 | 10.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.0 | 18.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
1.0 | 2.9 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
1.0 | 9.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.0 | 8.7 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.0 | 14.4 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
1.0 | 2.9 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
1.0 | 1.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
1.0 | 11.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.0 | 5.7 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
0.9 | 3.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.9 | 3.8 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.9 | 4.7 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.9 | 16.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.9 | 43.4 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.9 | 2.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.9 | 4.7 | GO:0033668 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.9 | 0.9 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.9 | 2.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.9 | 0.9 | GO:0097695 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.9 | 14.9 | GO:0046697 | decidualization(GO:0046697) |
0.9 | 3.7 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.9 | 20.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.9 | 11.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.9 | 6.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.9 | 2.8 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.9 | 3.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.9 | 6.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.9 | 11.0 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.9 | 3.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.9 | 4.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.9 | 23.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.9 | 2.8 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.9 | 3.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.9 | 1.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.9 | 9.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.9 | 6.4 | GO:0042775 | ATP synthesis coupled electron transport(GO:0042773) mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.9 | 11.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.9 | 2.7 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.9 | 9.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.9 | 3.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.9 | 13.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.9 | 4.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.9 | 1.8 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.9 | 53.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.9 | 55.9 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.9 | 40.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.9 | 16.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.9 | 1.7 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.9 | 1.7 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.9 | 17.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.9 | 2.6 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.9 | 35.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.9 | 4.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.9 | 6.9 | GO:0034508 | centromere complex assembly(GO:0034508) kinetochore assembly(GO:0051382) |
0.9 | 6.9 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.9 | 0.9 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.9 | 2.6 | GO:0007538 | primary sex determination(GO:0007538) |
0.9 | 1.7 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.9 | 3.4 | GO:1900246 | positive regulation of MDA-5 signaling pathway(GO:1900245) positive regulation of RIG-I signaling pathway(GO:1900246) |
0.9 | 8.5 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.9 | 1.7 | GO:1901656 | glycoside transport(GO:1901656) |
0.9 | 2.6 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.9 | 6.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.8 | 1.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.8 | 24.4 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.8 | 5.0 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.8 | 9.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.8 | 104.8 | GO:0006457 | protein folding(GO:0006457) |
0.8 | 2.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.8 | 8.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.8 | 11.6 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.8 | 6.6 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.8 | 70.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.8 | 4.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.8 | 19.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.8 | 13.8 | GO:0019835 | cytolysis(GO:0019835) |
0.8 | 18.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.8 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.8 | 2.4 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.8 | 14.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.8 | 6.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.8 | 0.8 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.8 | 1.6 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.8 | 5.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.8 | 4.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.8 | 23.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.8 | 3.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.8 | 6.3 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.8 | 1.6 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.8 | 3.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.8 | 3.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.8 | 4.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.8 | 52.2 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.8 | 3.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.8 | 7.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.8 | 3.8 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.8 | 3.0 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.8 | 3.0 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.7 | 2.2 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.7 | 2.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.7 | 7.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.7 | 0.7 | GO:1903513 | endoplasmic reticulum to cytosol transport(GO:1903513) |
0.7 | 20.5 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.7 | 5.9 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.7 | 5.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.7 | 6.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.7 | 1.4 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.7 | 2.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.7 | 5.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.7 | 2.8 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.7 | 2.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 2.1 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.7 | 3.5 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.7 | 2.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 2.8 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.7 | 1.4 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.7 | 0.7 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.7 | 4.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.7 | 6.9 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.7 | 8.9 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.7 | 3.4 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.7 | 1.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.7 | 6.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.7 | 1.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.7 | 4.6 | GO:0034205 | beta-amyloid formation(GO:0034205) |
0.7 | 8.6 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.7 | 4.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.7 | 24.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.7 | 1.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 3.3 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.7 | 8.5 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.6 | 7.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.6 | 1.9 | GO:0001881 | receptor recycling(GO:0001881) |
0.6 | 9.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 3.2 | GO:0009838 | abscission(GO:0009838) |
0.6 | 1.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.6 | 1.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.6 | 1.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 2.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.6 | 3.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 4.4 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.6 | 3.1 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.6 | 1.2 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.6 | 0.6 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.6 | 2.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.6 | 1.8 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.6 | 36.6 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.6 | 0.6 | GO:1903826 | arginine transport(GO:0015809) arginine transmembrane transport(GO:1903826) |
0.6 | 10.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.6 | 7.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.6 | 0.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.6 | 7.7 | GO:0002021 | response to dietary excess(GO:0002021) |
0.6 | 6.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.6 | 10.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.6 | 67.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.6 | 1.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.6 | 7.0 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.6 | 2.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.6 | 4.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.6 | 2.3 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.6 | 31.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.6 | 3.4 | GO:0033008 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.6 | 5.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.6 | 17.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.6 | 9.1 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.6 | 19.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.6 | 1.7 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.6 | 14.1 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.6 | 1.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.6 | 2.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.6 | 48.4 | GO:0002576 | platelet degranulation(GO:0002576) |
0.6 | 1.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.5 | 8.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.5 | 2.7 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.5 | 4.8 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.5 | 3.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.5 | 12.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.5 | 1.1 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.5 | 1.6 | GO:0090382 | phagosome maturation(GO:0090382) |
0.5 | 5.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.5 | 0.5 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.5 | 2.1 | GO:0006868 | glutamine transport(GO:0006868) glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.5 | 2.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 161.2 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.5 | 1.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 4.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.5 | 1.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.5 | 5.7 | GO:0007614 | short-term memory(GO:0007614) |
0.5 | 2.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.5 | 3.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.5 | 1.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 1.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.5 | 1.5 | GO:0032252 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) secretory granule localization(GO:0032252) |
0.5 | 1.0 | GO:2000562 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.5 | 2.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.5 | 1.5 | GO:1902499 | regulation of protein autoubiquitination(GO:1902498) positive regulation of protein autoubiquitination(GO:1902499) |
0.5 | 2.4 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.5 | 4.3 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.5 | 1.0 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.5 | 4.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.5 | 0.9 | GO:0009209 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.5 | 6.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.5 | 1.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.5 | 1.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.5 | 5.0 | GO:0046688 | response to copper ion(GO:0046688) |
0.5 | 2.7 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.5 | 1.4 | GO:0030242 | pexophagy(GO:0030242) |
0.5 | 13.5 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.5 | 2.3 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.4 | 0.9 | GO:0070372 | regulation of ERK1 and ERK2 cascade(GO:0070372) |
0.4 | 3.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.4 | 0.9 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 2.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 1.3 | GO:0090148 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) membrane fission(GO:0090148) |
0.4 | 3.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.4 | 0.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.4 | 2.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.4 | 4.6 | GO:0035268 | protein mannosylation(GO:0035268) |
0.4 | 3.3 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 2.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.4 | 14.4 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 3.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.4 | 9.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.4 | 3.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.4 | 1.2 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.4 | 3.5 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.4 | 1.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 3.5 | GO:0007567 | parturition(GO:0007567) |
0.4 | 0.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 2.7 | GO:0071692 | sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 0.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 0.7 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) |
0.4 | 1.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 1.1 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 1.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.4 | 0.4 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.4 | 2.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 3.5 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 0.3 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.3 | 2.8 | GO:0021591 | ventricular system development(GO:0021591) |
0.3 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 1.7 | GO:1905247 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.3 | 2.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 | 3.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 2.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 2.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.3 | 2.0 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.3 | 3.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 1.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 0.6 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.3 | 1.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 1.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.3 | 0.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.3 | 0.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.3 | 2.1 | GO:0099630 | postsynaptic neurotransmitter receptor cycle(GO:0099630) |
0.3 | 9.4 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.3 | 1.2 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.3 | 1.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.3 | 0.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 3.8 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.3 | 1.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.3 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.3 | 0.3 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.3 | 0.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.3 | 0.8 | GO:0046060 | dATP metabolic process(GO:0046060) dATP catabolic process(GO:0046061) |
0.3 | 1.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 6.7 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.3 | 1.6 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.3 | 3.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.3 | 5.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.3 | 4.5 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.3 | 1.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 4.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.3 | 1.0 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.0 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.2 | 1.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 0.5 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 2.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 1.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 3.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 3.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 0.9 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.2 | 0.9 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 | 0.6 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) maintenance of ER location(GO:0051685) |
0.2 | 2.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 0.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 21.0 | GO:0070268 | cornification(GO:0070268) |
0.2 | 1.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.6 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.2 | 0.6 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 | 1.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.4 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 2.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.2 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 1.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 0.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.3 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.2 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.8 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 5.3 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 1.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 1.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.2 | 0.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.7 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.1 | 0.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.9 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 0.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.4 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.1 | 4.1 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.1 | 1.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.5 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 1.8 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 1.7 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 1.3 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 1.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.4 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.6 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.1 | 1.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 5.6 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.8 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.1 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.1 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.7 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 2.3 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 1.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 2.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.4 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 1.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.7 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.1 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.9 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 1.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 1.6 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.1 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.1 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 0.3 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.5 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 1.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.2 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.0 | 0.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 2.4 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.3 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.6 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.2 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.0 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.0 | 0.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.5 | 70.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
17.5 | 17.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
17.2 | 51.6 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
14.1 | 84.9 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
13.7 | 41.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
12.3 | 36.9 | GO:0031523 | Myb complex(GO:0031523) |
11.9 | 59.3 | GO:0097422 | tubular endosome(GO:0097422) |
11.6 | 23.2 | GO:0005642 | annulate lamellae(GO:0005642) |
11.3 | 67.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
10.0 | 50.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
9.7 | 9.7 | GO:0070695 | FHF complex(GO:0070695) |
9.7 | 29.1 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
9.1 | 36.5 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
9.0 | 36.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
8.9 | 26.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
8.7 | 78.4 | GO:0005955 | calcineurin complex(GO:0005955) |
8.4 | 58.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
7.9 | 63.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
7.5 | 22.5 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
7.5 | 89.8 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
7.5 | 44.8 | GO:0071817 | MMXD complex(GO:0071817) |
7.4 | 29.5 | GO:0055087 | Ski complex(GO:0055087) |
7.3 | 73.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
6.9 | 34.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
6.8 | 20.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
6.7 | 40.3 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
6.6 | 59.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
6.6 | 92.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
6.5 | 84.7 | GO:0016600 | flotillin complex(GO:0016600) |
6.4 | 122.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
6.3 | 75.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
6.2 | 81.1 | GO:0005916 | fascia adherens(GO:0005916) |
6.1 | 30.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
6.0 | 30.2 | GO:0001940 | male pronucleus(GO:0001940) |
5.8 | 17.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
5.8 | 23.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
5.6 | 44.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
5.5 | 44.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
5.5 | 76.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
5.4 | 43.2 | GO:0097255 | R2TP complex(GO:0097255) |
5.3 | 21.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
5.3 | 37.1 | GO:0016589 | NURF complex(GO:0016589) |
5.3 | 26.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
5.3 | 15.9 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
5.3 | 42.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
5.2 | 26.2 | GO:0032449 | CBM complex(GO:0032449) |
5.2 | 89.0 | GO:0034709 | methylosome(GO:0034709) |
5.1 | 76.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
5.0 | 15.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
4.9 | 88.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
4.7 | 23.5 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
4.7 | 18.8 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
4.7 | 93.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
4.6 | 59.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
4.6 | 45.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
4.5 | 13.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
4.5 | 59.0 | GO:0097470 | ribbon synapse(GO:0097470) |
4.5 | 18.1 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
4.5 | 85.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
4.5 | 18.0 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
4.5 | 36.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
4.3 | 34.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
4.3 | 17.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
4.2 | 114.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
4.2 | 21.0 | GO:0071797 | LUBAC complex(GO:0071797) |
4.2 | 25.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
4.2 | 12.5 | GO:0045180 | basal cortex(GO:0045180) |
4.1 | 190.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
4.1 | 4.1 | GO:0044393 | microspike(GO:0044393) |
4.1 | 28.6 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
4.1 | 32.6 | GO:0042382 | paraspeckles(GO:0042382) |
4.1 | 20.3 | GO:0032021 | NELF complex(GO:0032021) |
4.0 | 8.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
4.0 | 23.8 | GO:0090661 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
4.0 | 23.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
3.9 | 15.8 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
3.9 | 19.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
3.9 | 35.0 | GO:0000796 | condensin complex(GO:0000796) |
3.9 | 27.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
3.9 | 54.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
3.8 | 23.0 | GO:0001740 | Barr body(GO:0001740) |
3.8 | 68.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
3.8 | 7.6 | GO:1903349 | omegasome membrane(GO:1903349) |
3.8 | 19.0 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
3.8 | 11.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
3.8 | 11.3 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
3.7 | 15.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
3.7 | 85.8 | GO:0032156 | septin cytoskeleton(GO:0032156) |
3.7 | 18.6 | GO:0070470 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
3.7 | 14.8 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
3.6 | 21.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
3.6 | 39.6 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
3.6 | 17.9 | GO:0035061 | interchromatin granule(GO:0035061) |
3.6 | 510.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
3.5 | 17.6 | GO:0097452 | GAIT complex(GO:0097452) |
3.5 | 24.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
3.5 | 73.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
3.5 | 14.0 | GO:0032301 | MutSalpha complex(GO:0032301) |
3.5 | 52.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
3.5 | 94.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
3.5 | 51.9 | GO:0032433 | filopodium tip(GO:0032433) |
3.4 | 10.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
3.4 | 3.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
3.4 | 47.5 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
3.4 | 60.8 | GO:0036020 | endolysosome membrane(GO:0036020) |
3.3 | 10.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
3.3 | 13.4 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
3.3 | 10.0 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
3.3 | 23.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
3.3 | 26.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
3.2 | 31.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
3.2 | 3.2 | GO:0071203 | WASH complex(GO:0071203) |
3.2 | 25.3 | GO:0090543 | Flemming body(GO:0090543) |
3.1 | 9.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
3.1 | 18.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
3.0 | 18.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
3.0 | 72.6 | GO:0071564 | npBAF complex(GO:0071564) |
3.0 | 21.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
3.0 | 9.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
2.9 | 31.7 | GO:0033643 | host cell part(GO:0033643) |
2.9 | 28.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
2.9 | 20.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
2.8 | 17.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
2.8 | 452.9 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
2.8 | 11.0 | GO:0070985 | TFIIK complex(GO:0070985) |
2.8 | 22.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
2.7 | 13.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.7 | 8.2 | GO:0034455 | t-UTP complex(GO:0034455) |
2.7 | 8.1 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
2.7 | 32.3 | GO:0097433 | dense body(GO:0097433) |
2.7 | 2.7 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
2.7 | 24.1 | GO:0005638 | lamin filament(GO:0005638) |
2.7 | 34.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
2.6 | 26.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
2.6 | 10.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
2.6 | 7.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
2.6 | 7.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
2.6 | 77.4 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
2.6 | 18.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
2.6 | 33.5 | GO:0005869 | dynactin complex(GO:0005869) |
2.5 | 10.1 | GO:0030891 | VCB complex(GO:0030891) |
2.5 | 17.7 | GO:0031415 | NatA complex(GO:0031415) |
2.5 | 2.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
2.5 | 4.9 | GO:0005771 | multivesicular body(GO:0005771) |
2.4 | 4.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
2.4 | 51.1 | GO:0031143 | pseudopodium(GO:0031143) |
2.4 | 29.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
2.4 | 12.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
2.4 | 16.9 | GO:0061617 | MICOS complex(GO:0061617) |
2.4 | 12.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
2.4 | 26.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
2.4 | 11.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
2.4 | 66.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.4 | 7.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
2.3 | 32.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
2.3 | 11.6 | GO:0070938 | contractile ring(GO:0070938) |
2.3 | 6.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.3 | 11.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
2.3 | 20.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
2.3 | 40.6 | GO:0030056 | hemidesmosome(GO:0030056) |
2.2 | 11.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
2.2 | 13.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
2.2 | 24.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
2.2 | 39.7 | GO:0005685 | U1 snRNP(GO:0005685) |
2.2 | 60.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.2 | 6.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
2.2 | 12.9 | GO:0005688 | U6 snRNP(GO:0005688) |
2.1 | 17.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
2.1 | 128.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
2.1 | 8.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
2.1 | 10.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
2.1 | 19.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.1 | 19.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
2.1 | 29.6 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
2.1 | 8.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
2.1 | 14.7 | GO:0033269 | internode region of axon(GO:0033269) |
2.1 | 14.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
2.1 | 23.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
2.1 | 16.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
2.1 | 24.6 | GO:0000346 | transcription export complex(GO:0000346) |
2.1 | 4.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.0 | 51.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
2.0 | 10.2 | GO:0000125 | PCAF complex(GO:0000125) |
2.0 | 6.1 | GO:0018444 | translation release factor complex(GO:0018444) |
2.0 | 12.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
2.0 | 16.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.0 | 8.0 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
1.9 | 3.9 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
1.9 | 3.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.9 | 5.8 | GO:0097441 | basilar dendrite(GO:0097441) |
1.9 | 11.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
1.9 | 201.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
1.9 | 101.7 | GO:0005876 | spindle microtubule(GO:0005876) |
1.9 | 42.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.9 | 15.3 | GO:0008091 | spectrin(GO:0008091) |
1.9 | 7.6 | GO:1990423 | RZZ complex(GO:1990423) |
1.9 | 1.9 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
1.9 | 5.7 | GO:0016938 | kinesin I complex(GO:0016938) |
1.9 | 9.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.9 | 7.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.9 | 3.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
1.8 | 993.0 | GO:0005925 | focal adhesion(GO:0005925) |
1.8 | 27.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
1.8 | 7.3 | GO:0000811 | GINS complex(GO:0000811) |
1.8 | 5.4 | GO:0043291 | RAVE complex(GO:0043291) |
1.8 | 8.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
1.8 | 5.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.8 | 1.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.7 | 5.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.7 | 12.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.7 | 10.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
1.7 | 5.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.7 | 24.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
1.7 | 8.3 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
1.7 | 13.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
1.7 | 8.3 | GO:0001739 | sex chromatin(GO:0001739) |
1.6 | 24.7 | GO:0000812 | Swr1 complex(GO:0000812) |
1.6 | 51.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.6 | 4.9 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
1.6 | 37.7 | GO:0046930 | pore complex(GO:0046930) |
1.6 | 47.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
1.6 | 4.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.6 | 1.6 | GO:0030681 | multimeric ribonuclease P complex(GO:0030681) |
1.6 | 152.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
1.6 | 3.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.6 | 8.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.6 | 23.3 | GO:0000145 | exocyst(GO:0000145) |
1.6 | 12.4 | GO:0097413 | Lewy body(GO:0097413) |
1.5 | 4.6 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
1.5 | 79.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.5 | 6.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.5 | 10.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.5 | 1.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
1.5 | 10.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.5 | 10.2 | GO:0016272 | prefoldin complex(GO:0016272) |
1.5 | 7.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.4 | 27.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.4 | 2.9 | GO:0071159 | NF-kappaB complex(GO:0071159) |
1.4 | 5.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.4 | 47.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.4 | 5.6 | GO:0044308 | axonal spine(GO:0044308) |
1.4 | 4.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.4 | 9.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.3 | 8.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.3 | 28.0 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
1.3 | 1.3 | GO:0031261 | nuclear pre-replicative complex(GO:0005656) DNA replication preinitiation complex(GO:0031261) pre-replicative complex(GO:0036387) |
1.3 | 12.0 | GO:0032059 | bleb(GO:0032059) |
1.3 | 6.5 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
1.3 | 6.5 | GO:0070852 | cell body fiber(GO:0070852) |
1.3 | 15.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.3 | 9.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
1.3 | 29.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.3 | 7.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.3 | 76.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.2 | 3.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.2 | 8.6 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
1.2 | 9.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.2 | 4.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.2 | 3.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.2 | 4.9 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
1.2 | 6.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.2 | 45.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
1.2 | 14.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.2 | 7.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.2 | 12.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
1.2 | 4.7 | GO:0032044 | DSIF complex(GO:0032044) |
1.2 | 9.3 | GO:0044754 | autolysosome(GO:0044754) |
1.2 | 10.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
1.1 | 11.5 | GO:0030904 | retromer complex(GO:0030904) |
1.1 | 76.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
1.1 | 4.5 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
1.1 | 28.9 | GO:0043034 | costamere(GO:0043034) |
1.1 | 2.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.1 | 16.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
1.1 | 13.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.1 | 6.5 | GO:0072686 | mitotic spindle(GO:0072686) |
1.1 | 59.2 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
1.1 | 1.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.1 | 71.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.1 | 3.2 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
1.0 | 17.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.0 | 12.4 | GO:0030008 | TRAPP complex(GO:0030008) |
1.0 | 2.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.0 | 48.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.0 | 59.8 | GO:0005811 | lipid particle(GO:0005811) |
1.0 | 7.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
1.0 | 2.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.0 | 10.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 2.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.0 | 10.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.9 | 18.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.9 | 3.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.9 | 25.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.9 | 9.7 | GO:0042555 | MCM complex(GO:0042555) |
0.9 | 3.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.9 | 6.9 | GO:0031941 | filamentous actin(GO:0031941) |
0.9 | 66.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.9 | 7.8 | GO:0061574 | ASAP complex(GO:0061574) |
0.9 | 3.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 2207.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.8 | 9.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.8 | 2.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.8 | 4.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.8 | 0.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.8 | 2.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.8 | 2.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.8 | 23.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.8 | 0.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.8 | 6.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 36.7 | GO:0031902 | late endosome membrane(GO:0031902) |
0.7 | 9.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.7 | 1.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.7 | 5.0 | GO:0070187 | telosome(GO:0070187) |
0.7 | 0.7 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.7 | 2.1 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.7 | 25.7 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.7 | 4.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.7 | 4.0 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.6 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.6 | 3.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 5.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.6 | 4.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 15.4 | GO:1990904 | ribonucleoprotein complex(GO:1990904) |
0.6 | 2.8 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.6 | 1.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.5 | 11.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.5 | 2.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 5.9 | GO:0097346 | INO80-type complex(GO:0097346) |
0.5 | 3.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 4.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 3.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.5 | 0.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 3.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 7.6 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.5 | 1.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.5 | 3.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 2.3 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.5 | 19.8 | GO:0005903 | brush border(GO:0005903) |
0.4 | 12.1 | GO:0005921 | gap junction(GO:0005921) |
0.4 | 11.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.4 | 0.9 | GO:0044449 | contractile fiber part(GO:0044449) |
0.4 | 4.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.4 | 3.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.4 | 3.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 1.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.4 | 1.7 | GO:0070469 | respiratory chain(GO:0070469) |
0.4 | 1.3 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 8.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.4 | 3.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.4 | 13.3 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.4 | 1.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.4 | 15.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 62.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 5.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.4 | 6.3 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.4 | 0.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.4 | 1.2 | GO:0031674 | I band(GO:0031674) |
0.4 | 3.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 0.8 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.4 | 1.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.4 | 11.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 0.6 | GO:0044447 | axoneme part(GO:0044447) |
0.3 | 5.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 2.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 24.8 | GO:0000922 | spindle pole(GO:0000922) |
0.3 | 9.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 9.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 12.0 | GO:0035579 | specific granule membrane(GO:0035579) |
0.2 | 0.5 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 4.1 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 3.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 2.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 0.9 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) NatC complex(GO:0031417) |
0.2 | 1.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 3.0 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 6.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 8.4 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.5 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 1.7 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 30.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 2.4 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.2 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.8 | 99.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
22.9 | 68.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
16.4 | 82.0 | GO:0016403 | dimethylargininase activity(GO:0016403) |
12.6 | 37.8 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
12.3 | 73.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
12.2 | 36.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
11.9 | 83.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
10.9 | 98.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
10.8 | 43.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
10.4 | 41.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
10.0 | 10.0 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
10.0 | 30.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
9.9 | 29.8 | GO:0048030 | disaccharide binding(GO:0048030) |
9.9 | 39.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
9.5 | 38.0 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
9.5 | 47.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
9.4 | 37.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
9.1 | 63.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
8.6 | 43.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
8.6 | 34.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
8.5 | 84.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
8.4 | 33.6 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
8.2 | 33.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
8.2 | 32.8 | GO:0005046 | KDEL sequence binding(GO:0005046) |
8.1 | 40.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
8.1 | 24.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
7.8 | 23.4 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
7.8 | 23.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
7.8 | 54.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
7.8 | 31.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
7.5 | 30.0 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
7.4 | 80.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
7.3 | 44.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
7.3 | 7.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
7.3 | 43.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
7.3 | 21.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
7.0 | 21.1 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
7.0 | 35.0 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
6.8 | 20.5 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
6.8 | 20.4 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
6.8 | 68.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
6.7 | 26.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
6.5 | 78.4 | GO:0031386 | protein tag(GO:0031386) |
6.5 | 26.0 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
6.5 | 38.8 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
6.3 | 31.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
6.3 | 44.0 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
6.2 | 18.6 | GO:0032427 | GBD domain binding(GO:0032427) |
6.1 | 281.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
6.0 | 36.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
6.0 | 29.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
6.0 | 23.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
6.0 | 29.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
5.8 | 17.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
5.8 | 17.3 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
5.8 | 17.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
5.8 | 40.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
5.6 | 16.9 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
5.6 | 67.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
5.6 | 22.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
5.6 | 44.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
5.5 | 16.5 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
5.4 | 27.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
5.4 | 70.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
5.3 | 47.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
5.3 | 21.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
5.1 | 46.2 | GO:0015288 | porin activity(GO:0015288) |
5.1 | 35.7 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
5.1 | 20.4 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
5.1 | 40.8 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
5.1 | 15.3 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
5.1 | 15.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
5.0 | 15.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
5.0 | 9.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
4.9 | 19.6 | GO:0016936 | galactoside binding(GO:0016936) |
4.9 | 88.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
4.7 | 28.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
4.7 | 14.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
4.6 | 51.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
4.5 | 54.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
4.5 | 45.3 | GO:0042731 | PH domain binding(GO:0042731) |
4.5 | 9.0 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
4.5 | 4.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
4.5 | 8.9 | GO:0043398 | HLH domain binding(GO:0043398) |
4.4 | 22.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
4.4 | 52.7 | GO:0008199 | ferric iron binding(GO:0008199) |
4.4 | 17.5 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
4.4 | 21.8 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
4.3 | 13.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
4.3 | 12.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
4.3 | 4.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
4.2 | 143.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
4.2 | 25.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
4.2 | 12.6 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
4.1 | 49.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
4.1 | 12.3 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
4.1 | 40.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
4.1 | 12.2 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
4.0 | 20.1 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
4.0 | 23.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
4.0 | 83.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
3.9 | 19.7 | GO:0070404 | NADH binding(GO:0070404) |
3.9 | 11.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
3.9 | 27.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
3.9 | 11.6 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
3.8 | 11.4 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
3.8 | 26.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
3.7 | 11.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
3.7 | 11.2 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
3.7 | 29.7 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
3.7 | 40.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
3.6 | 10.9 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
3.6 | 25.4 | GO:0030911 | TPR domain binding(GO:0030911) |
3.6 | 18.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
3.6 | 35.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
3.6 | 46.2 | GO:0030957 | Tat protein binding(GO:0030957) |
3.5 | 14.1 | GO:1903135 | cupric ion binding(GO:1903135) |
3.5 | 14.0 | GO:0032143 | single thymine insertion binding(GO:0032143) |
3.5 | 10.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
3.5 | 249.3 | GO:0019003 | GDP binding(GO:0019003) |
3.4 | 96.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
3.4 | 27.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.4 | 10.2 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
3.4 | 20.4 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
3.4 | 10.1 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
3.3 | 10.0 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
3.3 | 86.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
3.3 | 66.5 | GO:0070628 | proteasome binding(GO:0070628) |
3.3 | 10.0 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
3.3 | 26.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
3.3 | 26.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
3.3 | 49.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.2 | 12.9 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
3.2 | 9.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
3.2 | 12.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
3.2 | 12.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
3.2 | 18.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
3.1 | 72.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
3.1 | 18.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
3.1 | 9.4 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
3.1 | 52.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
3.1 | 27.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
3.1 | 21.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
3.0 | 67.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
3.0 | 24.3 | GO:0004064 | arylesterase activity(GO:0004064) |
3.0 | 5.9 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
3.0 | 5.9 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
2.9 | 52.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.9 | 11.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
2.9 | 8.7 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
2.9 | 5.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
2.8 | 56.7 | GO:0044548 | S100 protein binding(GO:0044548) |
2.8 | 14.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
2.8 | 33.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.8 | 25.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
2.8 | 44.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.8 | 19.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
2.8 | 2.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
2.8 | 30.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
2.8 | 11.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
2.7 | 35.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
2.7 | 27.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
2.7 | 8.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.7 | 30.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
2.7 | 636.7 | GO:0051015 | actin filament binding(GO:0051015) |
2.7 | 2.7 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
2.7 | 8.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
2.7 | 10.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
2.6 | 15.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
2.6 | 39.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
2.6 | 13.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
2.6 | 7.9 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
2.6 | 7.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
2.6 | 20.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.6 | 100.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
2.6 | 76.6 | GO:0003785 | actin monomer binding(GO:0003785) |
2.5 | 2.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
2.5 | 121.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
2.5 | 10.1 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
2.5 | 80.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
2.5 | 7.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
2.5 | 7.5 | GO:0000150 | recombinase activity(GO:0000150) |
2.5 | 20.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
2.5 | 5.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
2.5 | 12.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
2.5 | 7.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
2.4 | 2.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
2.4 | 24.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
2.4 | 16.9 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
2.4 | 7.2 | GO:0034046 | poly(G) binding(GO:0034046) |
2.4 | 9.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
2.4 | 26.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
2.4 | 7.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
2.4 | 21.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
2.3 | 2.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
2.3 | 9.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
2.3 | 2.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
2.3 | 32.2 | GO:0000339 | RNA cap binding(GO:0000339) |
2.3 | 6.9 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
2.3 | 103.4 | GO:0050699 | WW domain binding(GO:0050699) |
2.3 | 6.8 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
2.3 | 2.3 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
2.2 | 13.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
2.2 | 6.7 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
2.2 | 37.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
2.2 | 8.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
2.2 | 13.3 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
2.2 | 30.9 | GO:0031489 | myosin V binding(GO:0031489) |
2.2 | 33.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
2.2 | 10.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
2.2 | 54.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
2.2 | 2.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
2.2 | 10.9 | GO:0038064 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
2.2 | 62.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
2.1 | 29.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.1 | 21.3 | GO:0015266 | protein channel activity(GO:0015266) |
2.1 | 825.7 | GO:0045296 | cadherin binding(GO:0045296) |
2.1 | 12.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
2.1 | 37.8 | GO:0001968 | fibronectin binding(GO:0001968) |
2.1 | 81.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
2.1 | 35.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
2.1 | 33.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
2.1 | 12.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.1 | 28.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.0 | 8.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
2.0 | 35.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.0 | 33.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
2.0 | 4.0 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
2.0 | 15.7 | GO:0048156 | tau protein binding(GO:0048156) |
2.0 | 82.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
2.0 | 13.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
2.0 | 7.8 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.9 | 5.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
1.9 | 56.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.9 | 9.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.9 | 30.3 | GO:0031491 | nucleosome binding(GO:0031491) |
1.9 | 9.5 | GO:0070026 | nitric oxide binding(GO:0070026) |
1.9 | 9.4 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
1.9 | 7.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.9 | 3.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.9 | 3.7 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
1.9 | 20.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.9 | 31.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
1.9 | 16.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
1.8 | 7.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.8 | 18.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
1.8 | 1.8 | GO:0032810 | sterol response element binding(GO:0032810) |
1.8 | 3.6 | GO:0048185 | activin binding(GO:0048185) |
1.8 | 9.1 | GO:1990254 | keratin filament binding(GO:1990254) |
1.8 | 434.5 | GO:0003924 | GTPase activity(GO:0003924) |
1.8 | 9.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
1.8 | 12.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.8 | 23.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.8 | 12.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.8 | 7.1 | GO:0036033 | mediator complex binding(GO:0036033) |
1.8 | 3.6 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
1.8 | 5.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
1.8 | 5.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.7 | 10.4 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
1.7 | 5.1 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
1.7 | 6.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
1.7 | 32.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
1.7 | 6.8 | GO:0004335 | galactokinase activity(GO:0004335) |
1.7 | 45.7 | GO:0070717 | poly-purine tract binding(GO:0070717) |
1.7 | 6.8 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
1.7 | 3.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.7 | 8.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.7 | 19.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.7 | 68.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.6 | 102.1 | GO:0005507 | copper ion binding(GO:0005507) |
1.6 | 13.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.6 | 50.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.6 | 18.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.6 | 11.4 | GO:0050733 | RS domain binding(GO:0050733) |
1.6 | 16.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.6 | 16.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
1.6 | 3.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.6 | 30.8 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
1.6 | 42.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
1.6 | 4.8 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
1.6 | 11.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.6 | 4.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.6 | 44.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.6 | 46.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.6 | 4.8 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
1.6 | 7.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.6 | 12.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.6 | 4.7 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.6 | 20.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.6 | 3.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.6 | 4.7 | GO:0003883 | CTP synthase activity(GO:0003883) |
1.6 | 29.5 | GO:0008483 | transaminase activity(GO:0008483) |
1.6 | 17.1 | GO:0008494 | translation activator activity(GO:0008494) |
1.5 | 4.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.5 | 10.8 | GO:0034452 | dynactin binding(GO:0034452) |
1.5 | 4.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.5 | 18.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.5 | 6.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.5 | 13.7 | GO:0043426 | MRF binding(GO:0043426) |
1.5 | 6.0 | GO:0071253 | connexin binding(GO:0071253) |
1.5 | 16.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.5 | 11.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
1.5 | 2.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.5 | 5.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.5 | 11.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.5 | 5.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.5 | 26.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
1.4 | 7.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
1.4 | 5.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.4 | 21.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
1.4 | 5.7 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.4 | 5.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.4 | 9.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.4 | 53.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.4 | 2.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.4 | 5.6 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.4 | 18.1 | GO:0005521 | lamin binding(GO:0005521) |
1.4 | 1.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.4 | 6.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.4 | 2.7 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
1.4 | 31.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.4 | 31.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.4 | 13.6 | GO:0070403 | NAD+ binding(GO:0070403) |
1.3 | 25.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.3 | 24.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.3 | 1.3 | GO:0051731 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.3 | 10.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.3 | 1.3 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
1.3 | 3.9 | GO:0019826 | oxygen sensor activity(GO:0019826) |
1.3 | 12.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.3 | 21.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.3 | 7.7 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
1.3 | 61.2 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.3 | 15.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.3 | 7.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.2 | 22.3 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
1.2 | 8.7 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
1.2 | 11.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.2 | 4.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.2 | 8.6 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
1.2 | 18.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
1.2 | 16.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.2 | 1.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.2 | 2.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
1.2 | 3.6 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
1.2 | 3.6 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
1.2 | 5.9 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
1.2 | 9.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.2 | 8.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.2 | 18.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.2 | 3.5 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
1.2 | 6.9 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
1.1 | 17.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.1 | 4.5 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
1.1 | 8.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
1.1 | 19.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.1 | 12.0 | GO:0031402 | sodium ion binding(GO:0031402) |
1.1 | 12.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.1 | 4.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.1 | 8.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.1 | 28.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.1 | 3.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
1.1 | 32.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
1.0 | 3.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.0 | 6.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
1.0 | 3.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
1.0 | 7.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
1.0 | 2.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.0 | 4.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.0 | 7.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
1.0 | 6.0 | GO:0070513 | death domain binding(GO:0070513) |
1.0 | 22.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.0 | 27.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.0 | 14.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.0 | 10.9 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.0 | 16.8 | GO:0005537 | mannose binding(GO:0005537) |
1.0 | 26.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.0 | 2.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.0 | 4.8 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
1.0 | 74.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
1.0 | 26.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.0 | 9.6 | GO:0098505 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
1.0 | 12.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.0 | 55.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
1.0 | 2.9 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.9 | 3.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.9 | 18.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.9 | 15.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.9 | 0.9 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.9 | 7.5 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.9 | 0.9 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
0.9 | 2.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.9 | 25.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.9 | 3.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.9 | 7.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.9 | 2.8 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.9 | 64.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.9 | 1.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.9 | 167.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.9 | 4.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.9 | 25.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.9 | 11.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.9 | 2.6 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.9 | 10.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.9 | 74.3 | GO:0009055 | electron carrier activity(GO:0009055) |
0.9 | 1.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.9 | 19.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.9 | 2.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 4.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.9 | 3.4 | GO:0043295 | glutathione binding(GO:0043295) |
0.8 | 5.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.8 | 16.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.8 | 5.8 | GO:0052723 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.8 | 2.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 4.9 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.8 | 2.5 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.8 | 3.3 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.8 | 2.4 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.8 | 23.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.8 | 11.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.8 | 13.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.8 | 7.9 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.8 | 5.5 | GO:0046790 | virion binding(GO:0046790) |
0.8 | 4.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.8 | 19.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.8 | 2.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 7.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.7 | 2.2 | GO:0035473 | lipase binding(GO:0035473) |
0.7 | 13.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.7 | 16.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.7 | 17.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.7 | 2.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.7 | 2.1 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.7 | 28.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.7 | 14.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.7 | 12.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 3.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.7 | 1.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.7 | 16.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.7 | 4.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.7 | 22.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.7 | 1.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.7 | 3.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.6 | 2.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.6 | 3.2 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.6 | 2.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 5.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 1.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.6 | 1.9 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.6 | 1.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 2.5 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.6 | 0.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.6 | 2.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.6 | 3.5 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.6 | 4.0 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.6 | 2.8 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.6 | 60.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 2.3 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.6 | 20.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.6 | 0.6 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.5 | 2.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.5 | 29.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.5 | 16.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 3.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 1.6 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.5 | 6.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 2.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 2.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 2.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.5 | 2.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 2.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.5 | 33.6 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.5 | 1.0 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.5 | 21.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.5 | 2.5 | GO:0045569 | TRAIL binding(GO:0045569) |
0.5 | 1.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 30.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 35.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.5 | 2.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.5 | 1.5 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.5 | 5.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.5 | 0.5 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.5 | 3.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.5 | 1.4 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.4 | 3.6 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 4.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 4.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 1.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 0.9 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 2.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 3.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 4.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.4 | 5.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.4 | 2.0 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.4 | 2.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 6.4 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.4 | 84.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.4 | 1.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.4 | 1.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 2.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 3.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.4 | 1.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.4 | 5.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 4.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.4 | 2.6 | GO:0089720 | caspase binding(GO:0089720) |
0.4 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 12.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 3.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.3 | 2.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 5.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 2.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 21.5 | GO:0002020 | protease binding(GO:0002020) |
0.3 | 0.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 2.0 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.3 | 2.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 1.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 4.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 2.9 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.3 | 2.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 0.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.3 | 1.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.3 | 11.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 1.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 6.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.3 | 1.8 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.3 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 3.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.3 | 1.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 1.4 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.3 | 4.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.3 | 1.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.3 | 2.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 4.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 2.9 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.3 | 4.4 | GO:0015923 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.3 | 1.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.3 | 2.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 0.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 3.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 3.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 22.7 | GO:0020037 | heme binding(GO:0020037) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 1.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 6.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.2 | 10.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 1.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 26.0 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 5.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.8 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 15.8 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 9.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 1.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 1.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 1.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 2.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 5.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 1.0 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.2 | 0.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 4.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 1.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.8 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.2 | 0.2 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 153.9 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 7.5 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 1.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 3.7 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.4 | GO:0016791 | phosphatase activity(GO:0016791) |
0.1 | 0.3 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.4 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 7.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 2.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.2 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.2 | GO:0015350 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
0.0 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.5 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.9 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 253.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
4.9 | 282.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
4.9 | 171.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
3.7 | 292.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
3.3 | 164.0 | PID BARD1 PATHWAY | BARD1 signaling events |
3.3 | 123.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
3.2 | 32.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
3.2 | 79.3 | PID ARF 3PATHWAY | Arf1 pathway |
2.9 | 63.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
2.8 | 53.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
2.8 | 19.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
2.6 | 47.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
2.6 | 325.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
2.6 | 120.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
2.4 | 28.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
2.3 | 9.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
2.0 | 104.4 | PID AURORA B PATHWAY | Aurora B signaling |
2.0 | 44.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.9 | 35.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.9 | 69.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.8 | 62.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.8 | 65.8 | PID ALK1 PATHWAY | ALK1 signaling events |
1.8 | 91.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
1.7 | 52.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.7 | 38.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.7 | 25.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.7 | 75.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.6 | 11.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.6 | 56.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.6 | 42.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.5 | 74.0 | PID FOXO PATHWAY | FoxO family signaling |
1.5 | 34.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.5 | 13.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.5 | 19.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.5 | 1.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.4 | 90.1 | PID CDC42 PATHWAY | CDC42 signaling events |
1.4 | 17.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.4 | 8.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.3 | 95.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
1.3 | 52.3 | PID P53 REGULATION PATHWAY | p53 pathway |
1.3 | 17.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.2 | 9.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.2 | 47.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.2 | 48.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.1 | 119.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.1 | 1.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.0 | 10.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.0 | 65.9 | PID E2F PATHWAY | E2F transcription factor network |
1.0 | 26.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.0 | 5.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.0 | 24.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.9 | 24.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.9 | 22.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.9 | 4.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.8 | 8.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.8 | 43.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 28.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.7 | 43.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.7 | 35.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.7 | 19.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.7 | 9.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.7 | 15.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.7 | 23.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.7 | 11.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.7 | 4.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.6 | 8.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.6 | 36.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.6 | 1.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.6 | 9.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 4.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.6 | 13.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 16.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 8.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 4.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 3.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 19.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.5 | 25.1 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 18.8 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 8.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.5 | 3.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 2.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.4 | 9.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 10.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 9.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 5.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 9.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 8.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 42.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 8.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 17.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.4 | 2.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 8.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 12.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 7.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 2.1 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 5.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 48.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 4.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 3.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 4.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 4.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 1.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 5.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 109.4 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
7.3 | 197.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
7.2 | 144.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
6.2 | 80.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
6.2 | 55.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
5.6 | 44.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
5.4 | 91.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
5.0 | 139.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
4.9 | 234.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
4.6 | 129.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
4.5 | 351.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
4.5 | 22.5 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
4.5 | 102.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
4.1 | 207.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
4.0 | 75.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
3.9 | 92.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
3.8 | 69.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
3.8 | 122.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
3.8 | 7.5 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
3.6 | 83.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
3.6 | 71.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
3.6 | 100.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
3.6 | 32.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
3.5 | 20.9 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
3.5 | 166.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
3.5 | 41.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
3.4 | 81.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
3.4 | 40.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
3.3 | 83.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
3.3 | 143.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
3.2 | 74.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
3.2 | 57.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
3.1 | 68.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
3.1 | 120.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
3.0 | 30.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
3.0 | 98.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
2.9 | 99.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
2.8 | 190.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
2.8 | 109.7 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
2.8 | 25.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
2.8 | 85.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
2.8 | 16.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.7 | 38.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
2.7 | 188.5 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
2.7 | 61.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
2.7 | 159.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
2.7 | 50.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
2.6 | 26.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
2.6 | 62.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
2.6 | 67.4 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
2.5 | 81.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
2.5 | 129.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
2.5 | 118.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
2.5 | 7.5 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
2.5 | 59.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
2.4 | 87.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
2.4 | 24.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
2.4 | 62.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
2.4 | 40.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
2.3 | 11.7 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
2.3 | 39.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
2.3 | 333.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
2.3 | 240.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
2.2 | 15.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
2.2 | 48.7 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
2.2 | 4.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
2.2 | 10.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
2.1 | 85.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.1 | 22.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
2.0 | 60.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.9 | 29.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.9 | 285.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.9 | 46.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.8 | 36.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.8 | 14.7 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
1.8 | 32.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.8 | 19.6 | REACTOME OPSINS | Genes involved in Opsins |
1.8 | 86.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.7 | 38.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.7 | 17.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.7 | 69.1 | REACTOME S PHASE | Genes involved in S Phase |
1.7 | 23.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.7 | 40.6 | REACTOME KINESINS | Genes involved in Kinesins |
1.7 | 25.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.7 | 18.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.7 | 30.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.6 | 41.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.6 | 25.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.6 | 15.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.5 | 58.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
1.5 | 19.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.5 | 56.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.5 | 27.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.5 | 17.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.4 | 18.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.4 | 2.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.4 | 48.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.4 | 14.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.4 | 7.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.4 | 2.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.4 | 2.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.4 | 17.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.3 | 8.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
1.3 | 67.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.3 | 38.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.3 | 37.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.2 | 57.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.2 | 79.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.2 | 26.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.1 | 28.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.0 | 9.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.0 | 228.8 | REACTOME TRANSLATION | Genes involved in Translation |
1.0 | 13.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.0 | 4.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
1.0 | 80.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
1.0 | 17.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.9 | 4.7 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.9 | 14.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.9 | 19.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.9 | 7.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.9 | 52.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.9 | 18.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.8 | 0.8 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.8 | 54.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.8 | 5.8 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.8 | 28.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.8 | 69.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.8 | 9.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.8 | 26.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.7 | 12.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.7 | 2.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.7 | 10.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.6 | 7.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.6 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 3.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.6 | 14.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 30.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.5 | 2.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.5 | 5.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 10.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 6.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.5 | 4.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 9.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 4.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 11.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 5.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 10.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 15.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.4 | 5.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.4 | 4.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 2.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 5.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 6.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 12.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 9.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.3 | 5.1 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.3 | 5.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 6.9 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 5.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 4.5 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.2 | 3.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 3.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 4.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 1.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.2 | 17.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 2.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 6.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 18.6 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.1 | 2.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 2.8 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.2 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 2.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |